Crane NXT Reports Sharp Q1 Profit Decline Despite Revenue Growth, Driven by Acquisition Costs and Higher Debt
CXT sits 16% above its 52-week low of $39.23.
Summary
Crane NXT reported a 17.4% increase in Q1 2026 net sales but a 70.5% drop in net income and 71.05% decline in diluted EPS, largely due to costs and increased debt from the $418.2 million Antares Vision acquisition.
Key Events · Earnings and Guidance · CXT
-
Significant Profitability Decline
Net income attributable to common shareholders decreased by 70.5% to $6.4 million, and diluted EPS fell by 71.05% to $0.11 for Q1 2026 compared to Q1 2025.
-
Revenue Growth
Net sales increased by 17.4% to $387.7 million in Q1 2026, driven by the De La Rue acquisition and organic growth in the Currency business.
-
Antares Vision Acquisition Completed
The multi-phase acquisition of Antares Vision S.p.A. was completed in Q1 2026 for a total consideration of $418.2 million, funded by a new Term Loan B facility.
-
Increased Debt and Interest Expense
Total debt rose from $1,139.5 million at December 31, 2025, to $1,508.9 million at March 31, 2026, leading to a 54.8% increase in interest expense to $17.8 million.
Analysis · CXT · Manufacturing
Crane NXT, Co. reported a significant decline in profitability for the first quarter of 2026, despite a notable increase in net sales. Net income attributable to common shareholders plummeted by 70.5% and diluted EPS fell by 71.05% year-over-year. This downturn was primarily driven by increased operating costs and expenses, including higher transaction-related expenses and stock-based compensation linked to the recently completed $418.2 million Antares Vision acquisition. The acquisition, while strategically expanding the company's portfolio and leading to the creation of a new 'Detection and Traceability Technologies' segment, also resulted in a substantial increase in total debt, contributing to higher interest expense. The pro forma net income data suggests the acquisitions are not immediately accretive to earnings, indicating short-term financial pressure from strategic expansion.
At the time of this filing, CXT was trading at $45.65 on NYSE in the Manufacturing sector, with a market capitalization of approximately $2.6B. The 52-week trading range was $39.23 to $69.00. This filing was assessed with negative market sentiment and an importance score of 8 out of 10.